Sector Chart Cardiol Therapeutics Inc.

Stocks

CRDL

CA14161Y2006

Biotechnology & Medical Research

Market Closed - Toronto S.E. 21:00:00 12/08/2026 BST			5-day change	1st Jan Change
2.120 ^CAD	+0.47%		+11.58%	+61.83%

08-12	Cardiol Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Cardiol Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
CARDIOL THERAPEUTICS INC.	176M	-	-	-	-	-
LONZA GROUP AG	48.72B
REVOLUTION MEDICINES, INC.	43.99B	-	-	-	-	-
BEONE MEDICINES AG	40.82B
IQVIA HOLDINGS INC.	39.79B
CELLTRION, INC.	32.7B